Evotec SE (EVO) Receivables - Net (2009 - 2026)
Evotec SE's (EVO) quarterly Receivables - Net came in at $112.0 million in Q2 2026, up 16.18% year-over-year from $96.4 million in Q2 2025, and down 2.64% quarter-over-quarter from $115.0 million in Q1 2026.
Analysis
Evotec SE (EVO) Receivables - Net (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Receivables - Net across 9 years of filings, most recently posting $112.0 million for Q2 2026.
- In Q2 2026, Receivables - Net rose 16.18% year-over-year to $112.0 million; the TTM figure through Jun 2026 stood at $112.0 million (up 16.18% YoY), while the FY2025 annual figure was $153.6 million, up 22.01% from the prior year.
- Receivables - Net came in at $112.0 million for Q2 2026 at Evotec SE, down from $115.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $220.5 million in Q2 2023 to a low of $96.4 million in Q2 2025.
- Average Receivables - Net over 5 years is $131.6 million, with a median of $118.3 million recorded in 2022.
- The largest YoY upside for Receivables - Net was 96.3% in 2023 against a maximum downside of 39.6% in 2023.
- Over 5 years, Receivables - Net stood at $175.3 million in 2022, then slumped by 39.6% to $105.9 million in 2023, then climbed by 17.41% to $124.3 million in 2024, then rose by 27.33% to $158.3 million in 2025, then dropped by 29.24% to $112.0 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $112.0 million in Q2 2026, $115.0 million in Q1 2026, and $158.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.00 Mn |
| Mar 31, 2026 | 115.04 Mn |
| Dec 31, 2025 | 158.27 Mn |
| Sep 30, 2025 | 121.31 Mn |
| Jun 30, 2025 | 96.40 Mn |
| Mar 31, 2025 | 175.96 Mn |
| Dec 31, 2024 | 124.30 Mn |
| Sep 30, 2024 | 107.34 Mn |
| Mar 31, 2024 | 125.82 Mn |
| Dec 31, 2023 | 105.87 Mn |
| Jun 30, 2023 | 220.50 Mn |
| Dec 31, 2022 | 175.28 Mn |
| Sep 30, 2022 | 118.28 Mn |
| Jun 30, 2022 | 112.33 Mn |
| Mar 31, 2022 | 105.31 Mn |
| Dec 31, 2021 | 151.09 Mn |
| Sep 30, 2021 | 106.20 Mn |
| Dec 31, 2020 | 43.50 Mn |
| Sep 30, 2010 | 6.36 Mn |
| Jun 30, 2010 | 8.70 Mn |